Verily Life Sciences LLC also known asVerily (formerlyGoogle Life Sciences), isAlphabet Inc.'s research organization devoted to the study oflife sciences.[3][4] The organization was formerly a division ofGoogle X, and as of December 2024, is operating as a standalone company under Alphabet.
On 9 September 2014, the then-Google X division Google Life Sciences acquired Lift Labs, the makers ofLiftware.[5]
On August 10, 2015,Sergey Brin announced that the organization would become an independent subsidiary ofAlphabet Inc.[6] On December 7, 2015, Google Life Sciences was renamed Verily.[7][8]
Verily Life Sciences in January 2019 raised $1 billion in funding.
In August 2020, Verily announced that it is entering into the insurance market with the launch of Coefficient Insurance Company. The new subsidiary will be backed by Swiss Re Group's commercial insurance unit.[10]
In October 2022, the first patient was screened fordiabetic retinopathy at the Baton Rouge Clinic using Verily Retinal Service.[12]
In September 2022, Verily announced longtime CEO Andy Conrad would step down as CEO in January 2023, to be replaced byStephen Gillett[13] who became CEO on January 3, 2023.[14]
In January 2023, fifteen percent of Verily's workforce was laid off as part of a broader restructuring by parent company, Alphabet.[15]The Information reported in August that Gillett had told employees they would stop relying on Alphabet on "a wide range of corporate services", signaling a potentialspin-out as an independent company.[16]
In June 2024, Verily decided to close its operations in Israel three years after opening a research and development center in the country. Verily staff in Israel are expected to leave by the third quarter of 2024. The company cited an effort to refocus its strategy on core products and projects as the reason for the closure.[18]
In August 2024, Verily moved its headquarters from South San Francisco toDallas citing significant investment and involvement in the Texas healthcare and technology sectors.[19] As of December 2024, Verily is acting as a standalone company under Alphabet.[20]
In September 2024, Verily expanded its wastewater testing services to Europe through a partnership withBangor University in Wales.[21]
Reuters reported in August 2023 that Alphabet spinning off Verily was seen as possible after Verily CEO Stephen Gillett announced it would end ties to several of Alphabet's services.[24] In October 2025, Google executive Heather Adkins stated that the company is in the process of selling or spinning off Verily.[25]
TheBaseline Study, a project to collect genetic, molecular, and wearable device information from enough people to create a picture of what a healthy human should be.[32]
Onduo, a chronic disease management platform for patient with Diabetes, developed in partnership withSanofi.[33]
Study Watch, a health-tracking watch for clinical trials.[34]
Contact lenses that allow people with diabetes to continually check their glucose levels using a non-intrusive method.[35] On November 16, 2018, Verily announced it discontinued this project.[36]
Smart shoes for health tracking and fall detection[37]
